The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study.

Nadiye AkdenizMuhammet Ali KaplanDoğan UncuMevlüde İnançSerap KayaFaysal DaneMehmet KüçükönerAyşe DemirciMehmet BiliciAyşe Gök DurnalıLokman KoralMehmet Ali Nahit ŞendurCihan ErolEsma TürkmenÖmer Fatih ÖlmezÖzgür AçıkgözŞahin LaçinHayriye ŞahinliZuhat UrakçıAbdurrahman Işıkdoğan

Published in: International journal of colorectal disease (2021)

In the adjuvant treatment of stage III CRC patients, three different 5-FU administration types in FOLFOX combination treatment can be used with similar efficiency and manageable toxicity.

Keyphrases

early stage
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
patient reported outcomes